129 related articles for article (PubMed ID: 36341766)
1. Effects of resveratrol supplementation on nitric oxide-mediated vascular outcomes in hypertension: A systematic review.
DiNatale JC; Crowe-White KM
Nitric Oxide; 2022 Dec; 129():74-81. PubMed ID: 36341766
[TBL] [Abstract][Full Text] [Related]
2. Resveratrol prevents endothelial nitric oxide synthase uncoupling and attenuates development of hypertension in spontaneously hypertensive rats.
Bhatt SR; Lokhandwala MF; Banday AA
Eur J Pharmacol; 2011 Sep; 667(1-3):258-64. PubMed ID: 21640096
[TBL] [Abstract][Full Text] [Related]
3. Resveratrol and endothelial nitric oxide.
Xia N; Förstermann U; Li H
Molecules; 2014 Oct; 19(10):16102-21. PubMed ID: 25302702
[TBL] [Abstract][Full Text] [Related]
4. Impact of trans-resveratrol-sulfates and -glucuronides on endothelial nitric oxide synthase activity, nitric oxide release and intracellular reactive oxygen species.
Ladurner A; Schachner D; Schueller K; Pignitter M; Heiss EH; Somoza V; Dirsch VM
Molecules; 2014 Oct; 19(10):16724-36. PubMed ID: 25329867
[TBL] [Abstract][Full Text] [Related]
5. Resveratrol: a multifunctional compound improving endothelial function. Editorial to: "Resveratrol supplementation gender independently improves endothelial reactivity and suppresses superoxide production in healthy rats" by S. Soylemez et al.
Li H; Förstermann U
Cardiovasc Drugs Ther; 2009 Dec; 23(6):425-9. PubMed ID: 19937102
[TBL] [Abstract][Full Text] [Related]
6. Resveratrol lowers blood pressure in spontaneously hypertensive rats via calcium-dependent endothelial NO production.
Li X; Dai Y; Yan S; Shi Y; Li J; Liu J; Cha L; Mu J
Clin Exp Hypertens; 2016; 38(3):287-93. PubMed ID: 27018796
[TBL] [Abstract][Full Text] [Related]
7. Reversal of doxorubicin-induced vascular dysfunction by resveratrol in rat thoracic aorta: Is there a possible role of nitric oxide synthase inhibition?
Olukman M; Can C; Erol A; Oktem G; Oral O; Cinar MG
Anadolu Kardiyol Derg; 2009 Aug; 9(4):260-6. PubMed ID: 19666426
[TBL] [Abstract][Full Text] [Related]
8. Resveratrol shows vasoprotective effect reducing oxidative stress without affecting metabolic disturbances in insulin-dependent diabetes of rabbits.
Akar F; Pektas MB; Tufan C; Soylemez S; Sepici A; Ulus AT; Gokalp B; Ozturk K; Surucu HS
Cardiovasc Drugs Ther; 2011 Apr; 25(2):119-31. PubMed ID: 20676927
[TBL] [Abstract][Full Text] [Related]
9. Resveratrol recruits rat muscle microvasculature via a nitric oxide-dependent mechanism that is blocked by TNFα.
Wang N; Ko SH; Chai W; Li G; Barrett EJ; Tao L; Cao W; Liu Z
Am J Physiol Endocrinol Metab; 2011 Jan; 300(1):E195-201. PubMed ID: 20978231
[TBL] [Abstract][Full Text] [Related]
10. Effects of resveratrol on eNOS in the endothelium and the perivascular adipose tissue.
Xia N; Förstermann U; Li H
Ann N Y Acad Sci; 2017 Sep; 1403(1):132-141. PubMed ID: 28672425
[TBL] [Abstract][Full Text] [Related]
11. Repeated and long-term treatment with physiological concentrations of resveratrol promotes NO production in vascular endothelial cells.
Takahashi S; Nakashima Y
Br J Nutr; 2012 Mar; 107(6):774-80. PubMed ID: 21791144
[TBL] [Abstract][Full Text] [Related]
12. SIRT1 regulates oxidant- and cigarette smoke-induced eNOS acetylation in endothelial cells: Role of resveratrol.
Arunachalam G; Yao H; Sundar IK; Caito S; Rahman I
Biochem Biophys Res Commun; 2010 Feb; 393(1):66-72. PubMed ID: 20102704
[TBL] [Abstract][Full Text] [Related]
13. Metabolites of flavonoid compounds preserve indices of endothelial cell nitric oxide bioavailability under glucotoxic conditions.
Qian Y; Babu PVA; Symons JD; Jalili T
Nutr Diabetes; 2017 Sep; 7(9):e286. PubMed ID: 28892039
[TBL] [Abstract][Full Text] [Related]
14. Resveratrol analog piceatannol restores the palmitic acid-induced impairment of insulin signaling and production of endothelial nitric oxide via activation of anti-inflammatory and antioxidative heme oxygenase-1 in human endothelial cells.
Jeong SO; Son Y; Lee JH; Cheong YK; Park SH; Chung HT; Pae HO
Mol Med Rep; 2015 Jul; 12(1):937-44. PubMed ID: 25815690
[TBL] [Abstract][Full Text] [Related]
15. Resveratrol improves intrahepatic endothelial dysfunction and reduces hepatic fibrosis and portal pressure in cirrhotic rats.
Di Pascoli M; Diví M; Rodríguez-Vilarrupla A; Rosado E; Gracia-Sancho J; Vilaseca M; Bosch J; García-Pagán JC
J Hepatol; 2013 May; 58(5):904-10. PubMed ID: 23262250
[TBL] [Abstract][Full Text] [Related]
16. Effect of antioxidants pQ510 and resveratrol on regulatory function of the endothelium in rats with modeled arterial hypertension.
Gumanova NG; Artyushkova EB; Metel'skaya VA; Kochkarov VI; Pokrovskaya TG; Danilenko LM; Korneev MM; Pokrovskii MV; Pashin EN
Bull Exp Biol Med; 2007 Jun; 143(6):678-81. PubMed ID: 18239799
[TBL] [Abstract][Full Text] [Related]
17. Resveratrol improves endothelial function: role of TNF{alpha} and vascular oxidative stress.
Zhang H; Zhang J; Ungvari Z; Zhang C
Arterioscler Thromb Vasc Biol; 2009 Aug; 29(8):1164-71. PubMed ID: 19478208
[TBL] [Abstract][Full Text] [Related]
18. A combination of isolated phytochemicals and botanical extracts lowers diastolic blood pressure in a randomized controlled trial of hypertensive subjects.
Biesinger S; Michaels HA; Quadros AS; Qian Y; Rabovsky AB; Badger RS; Jalili T
Eur J Clin Nutr; 2016 Jan; 70(1):10-6. PubMed ID: 26059745
[TBL] [Abstract][Full Text] [Related]
19. Resveratrol Treatment Normalizes the Endothelial Function and Blood Pressure in Ovariectomized Rats.
Fabricio V; Oishi JC; Biffe BG; Ruffoni LD; Silva KA; Nonaka KO; Rodrigues GJ
Arq Bras Cardiol; 2017 Feb; 108(2):116-121. PubMed ID: 28327868
[TBL] [Abstract][Full Text] [Related]
20. Resveratrol reverses endothelial nitric-oxide synthase uncoupling in apolipoprotein E knockout mice.
Xia N; Daiber A; Habermeier A; Closs EI; Thum T; Spanier G; Lu Q; Oelze M; Torzewski M; Lackner KJ; Münzel T; Förstermann U; Li H
J Pharmacol Exp Ther; 2010 Oct; 335(1):149-54. PubMed ID: 20610621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
